Bank Of Montreal Fulcrum Therapeutics, Inc. Transaction History
Bank Of Montreal
- $197 Billion
- Q2 2024
A detailed history of Bank Of Montreal transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 32,282 shares of FULC stock, worth $110,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,282Holding current value
$110,727% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
58.8MCall Options Held
4.33MPut Options Held
309K-
Ra Capital Management, L.P. Boston, MA11.6MShares$39.8 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$20.1 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$10.5 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$10.2 Million0.47% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $178M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...